Try our Advanced Search for more refined results

After Failed Cephalon Bid, Valeant Buys Sanitas For $443M

By Pete Brush (May 24, 2011, 1:24 PM EDT) -- Less than a month after getting outbid by Teva Pharmaceutical Industries Ltd. for Cephalon Inc., Valeant Pharmaceuticals International Inc. made good Tuesday on its promise to find other targets, snapping up Lithuanian generics maker AB Sanitas for $443 million in cash....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!